Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Novel insights into genetic susceptibility for colorectal cancer from transcriptome-wide association and functional investigation

Z. Chen, W. Song, XO. Shu, W. Wen, M. Devall, C. Dampier, F. Moratalla-Navarro, Q. Cai, J. Long, L. Van Kaer, L. Wu, JR. Huyghe, M. Thomas, L. Hsu, MO. Woods, D. Albanes, DD. Buchanan, A. Gsur, M. Hoffmeister, P. Vodicka, A. Wolk, LL. Marchand,...

. 2024 ; 116 (1) : 127-137. [pub] 20240110

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc24007616

Grantová podpora
P30 DK058404 NIDDK NIH HHS - United States
R37 CA227130 NCI NIH HHS - United States
R37 CA227130 NIH HHS - United States

BACKGROUND: Transcriptome-wide association studies have been successful in identifying candidate susceptibility genes for colorectal cancer (CRC). To strengthen susceptibility gene discovery, we conducted a large transcriptome-wide association study and an alternative splicing transcriptome-wide association study in CRC using improved genetic prediction models and performed in-depth functional investigations. METHODS: We analyzed RNA-sequencing data from normal colon tissues and genotype data from 423 European descendants to build genetic prediction models of gene expression and alternative splicing and evaluated model performance using independent RNA-sequencing data from normal colon tissues of the Genotype-Tissue Expression Project. We applied the verified models to genome-wide association studies (GWAS) summary statistics among 58 131 CRC cases and 67 347 controls of European ancestry to evaluate associations of genetically predicted gene expression and alternative splicing with CRC risk. We performed in vitro functional assays for 3 selected genes in multiple CRC cell lines. RESULTS: We identified 57 putative CRC susceptibility genes, which included the 48 genes from transcriptome-wide association studies and 15 genes from splicing transcriptome-wide association studies, at a Bonferroni-corrected P value less than .05. Of these, 16 genes were not previously implicated in CRC susceptibility, including a gene PDE7B (6q23.3) at locus previously not reported by CRC GWAS. Gene knockdown experiments confirmed the oncogenic roles for 2 unreported genes, TRPS1 and METRNL, and a recently reported gene, C14orf166. CONCLUSION: This study discovered new putative susceptibility genes of CRC and provided novel insights into the biological mechanisms underlying CRC development.

Center for Cancer Research Medical University of Vienna Vienna Austria

Colorectal Cancer Group ONCOBELL Program Institut de Recerca Biomedica de Bellvitge L'Hospitalet de Llobregat Barcelona Spain

Colorectal Oncogenomics Group Department of Clinical Pathology The University of Melbourne Parkville VIC Australia

Consortium for Biomedical Research in Epidemiology and Public Health Madrid Spain

Department of Biomedical Informatics Vanderbilt University School of Medicine Nashville TN USA

Department of Biostatistics University of Washington Seattle WA USA

Department of Clinical Sciences Faculty of Medicine and Health Sciences and Universitat de Barcelona Institute of Complex Systems L'Hospitalet de Llobregat Barcelona Spain

Department of Epidemiology University of Washington Seattle WA USA

Department of Molecular Biology of Cancer Institute of Experimental Medicine of the Czech Academy of Sciences Prague Czech Republic

Department of Pathology Microbiology and Immunology Vanderbilt University Medical Center Nashville TN USA

Department of Public Health Sciences Center for Public Health Genomics University of Virginia Charlottesville VA USA

Division of Cancer Epidemiology and Genetics National Cancer Institute National Institutes of Health Bethesda MD USA

Division of Clinical Epidemiology and Aging Research German Cancer Research Center Heidelberg Germany

Division of Epidemiology Department of Medicine Vanderbilt Epidemiology Center Vanderbilt Ingram Cancer Center Vanderbilt University School of Medicine Nashville TN USA

Faculty of Medicine and Biomedical Center in Pilsen Charles University Pilsen Czech Republic

Genetic Medicine and Family Cancer Clinic The Royal Melbourne Hospital Parkville VIC Australia

Institute of Biology and Medical Genetics 1st Faculty of Medicine Charles University Prague Czech Republic

Institute of Environmental Medicine Karolinska Institutet Stockholm Sweden

Memorial University of Newfoundland Discipline of Genetics St John's ON Canada

Oncology Data Analytics Program Catalan Institute of Oncology L'Hospitalet de Llobregat Barcelona Spain

Preventative Medicine University of Southern California Los Angeles CA USA

Public Health Sciences Division Fred Hutchinson Cancer Research Center Seattle WA USA

University of Hawaii Cancer Center Honolulu HI USA

University of Melbourne Centre for Cancer Research Victorian Comprehensive Cancer Centre Parkville VIC Australia

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24007616
003      
CZ-PrNML
005      
20240423160133.0
007      
ta
008      
240412s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1093/jnci/djad178 $2 doi
035    __
$a (PubMed)37632791
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Chen, Zhishan $u Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA
245    10
$a Novel insights into genetic susceptibility for colorectal cancer from transcriptome-wide association and functional investigation / $c Z. Chen, W. Song, XO. Shu, W. Wen, M. Devall, C. Dampier, F. Moratalla-Navarro, Q. Cai, J. Long, L. Van Kaer, L. Wu, JR. Huyghe, M. Thomas, L. Hsu, MO. Woods, D. Albanes, DD. Buchanan, A. Gsur, M. Hoffmeister, P. Vodicka, A. Wolk, LL. Marchand, AH. Wu, AI. Phipps, V. Moreno, P. Ulrike, W. Zheng, G. Casey, X. Guo
520    9_
$a BACKGROUND: Transcriptome-wide association studies have been successful in identifying candidate susceptibility genes for colorectal cancer (CRC). To strengthen susceptibility gene discovery, we conducted a large transcriptome-wide association study and an alternative splicing transcriptome-wide association study in CRC using improved genetic prediction models and performed in-depth functional investigations. METHODS: We analyzed RNA-sequencing data from normal colon tissues and genotype data from 423 European descendants to build genetic prediction models of gene expression and alternative splicing and evaluated model performance using independent RNA-sequencing data from normal colon tissues of the Genotype-Tissue Expression Project. We applied the verified models to genome-wide association studies (GWAS) summary statistics among 58 131 CRC cases and 67 347 controls of European ancestry to evaluate associations of genetically predicted gene expression and alternative splicing with CRC risk. We performed in vitro functional assays for 3 selected genes in multiple CRC cell lines. RESULTS: We identified 57 putative CRC susceptibility genes, which included the 48 genes from transcriptome-wide association studies and 15 genes from splicing transcriptome-wide association studies, at a Bonferroni-corrected P value less than .05. Of these, 16 genes were not previously implicated in CRC susceptibility, including a gene PDE7B (6q23.3) at locus previously not reported by CRC GWAS. Gene knockdown experiments confirmed the oncogenic roles for 2 unreported genes, TRPS1 and METRNL, and a recently reported gene, C14orf166. CONCLUSION: This study discovered new putative susceptibility genes of CRC and provided novel insights into the biological mechanisms underlying CRC development.
650    _2
$a lidé $7 D006801
650    12
$a transkriptom $7 D059467
650    _2
$a celogenomová asociační studie $7 D055106
650    _2
$a genetická predispozice k nemoci $7 D020022
650    _2
$a RNA $7 D012313
650    12
$a kolorektální nádory $x genetika $7 D015179
650    _2
$a jednonukleotidový polymorfismus $7 D020641
650    _2
$a represorové proteiny $x genetika $7 D012097
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Song, Wenqiang $u Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA $u Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA
700    1_
$a Shu, Xiao-Ou $u Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA
700    1_
$a Wen, Wanqing $u Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA $1 https://orcid.org/0000000230045168
700    1_
$a Devall, Matthew $u Department of Public Health Sciences, Center for Public Health Genomics, University of Virginia, Charlottesville, VA, USA $1 https://orcid.org/0000000159434397
700    1_
$a Dampier, Christopher $u Department of Public Health Sciences, Center for Public Health Genomics, University of Virginia, Charlottesville, VA, USA
700    1_
$a Moratalla-Navarro, Ferran $u Oncology Data Analytics Program, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain $u Colorectal Cancer Group, ONCOBELL Program, Institut de Recerca Biomedica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain $u Department of Clinical Sciences, Faculty of Medicine and Health Sciences and Universitat de Barcelona Institute of Complex Systems (UBICS), University of Barcelona (UB), L'Hospitalet de Llobregat, Barcelona, Spain $u Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain
700    1_
$a Cai, Qiuyin $u Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA
700    1_
$a Long, Jirong $u Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA
700    1_
$a Van Kaer, Luc $u Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA
700    1_
$a Wu, Lan $u Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA
700    1_
$a Huyghe, Jeroen R $u Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA $1 https://orcid.org/0000000160279806
700    1_
$a Thomas, Minta $u Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
700    1_
$a Hsu, Li $u Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA $u Department of Biostatistics, University of Washington, Seattle, WA, USA
700    1_
$a Woods, Michael O $u Memorial University of Newfoundland, Discipline of Genetics, St. John's, ON, Canada
700    1_
$a Albanes, Demetrius $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
700    1_
$a Buchanan, Daniel D $u Colorectal Oncogenomics Group, Department of Clinical Pathology, The University of Melbourne, Parkville, VIC, Australia $u University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Parkville, VIC, Australia $u Genetic Medicine and Family Cancer Clinic, The Royal Melbourne Hospital, Parkville, VIC, Australia $1 https://orcid.org/0000000322256675
700    1_
$a Gsur, Andrea $u Center for Cancer Research, Medical University of Vienna, Vienna, Austria $1 https://orcid.org/0000000297951528
700    1_
$a Hoffmeister, Michael $u Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany $1 https://orcid.org/0000000283073197
700    1_
$a Vodicka, Pavel $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic $u Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, Czech Republic $u Faculty of Medicine and Biomedical Center in Pilsen, Charles University, Pilsen, Czech Republic
700    1_
$a Wolk, Alicja $u Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden $1 https://orcid.org/0000000173876845
700    1_
$a Marchand, Loic Le $u University of Hawaii Cancer Center, Honolulu, HI, USA
700    1_
$a Wu, Anna H $u Preventative Medicine, University of Southern California, Los Angeles, CA, USA $1 https://orcid.org/000000030546902X
700    1_
$a Phipps, Amanda I $u Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA $u Department of Epidemiology, University of Washington, Seattle, WA, USA
700    1_
$a Moreno, Victor $u Oncology Data Analytics Program, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain $u Colorectal Cancer Group, ONCOBELL Program, Institut de Recerca Biomedica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain $u Department of Clinical Sciences, Faculty of Medicine and Health Sciences and Universitat de Barcelona Institute of Complex Systems (UBICS), University of Barcelona (UB), L'Hospitalet de Llobregat, Barcelona, Spain $u Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain $1 https://orcid.org/0000000228185487
700    1_
$a Ulrike, Peters $u Department of Epidemiology, University of Washington, Seattle, WA, USA
700    1_
$a Zheng, Wei $u Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA
700    1_
$a Casey, Graham $u Department of Public Health Sciences, Center for Public Health Genomics, University of Virginia, Charlottesville, VA, USA
700    1_
$a Guo, Xingyi $u Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA $u Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN, USA $1 https://orcid.org/0000000284966288
773    0_
$w MED00003002 $t Journal of the National Cancer Institute $x 1460-2105 $g Roč. 116, č. 1 (2024), s. 127-137
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37632791 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20240423160129 $b ABA008
999    __
$a ok $b bmc $g 2081547 $s 1217383
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 116 $c 1 $d 127-137 $e 20240110 $i 1460-2105 $m Journal of the National Cancer Institute $n J Natl Cancer Inst $x MED00003002
GRA    __
$a P30 DK058404 $p NIDDK NIH HHS $2 United States
GRA    __
$a R37 CA227130 $p NCI NIH HHS $2 United States
GRA    __
$a R37 CA227130 $p NIH HHS $2 United States
LZP    __
$a Pubmed-20240412

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...